FDA Panel Will Review Acorn’s CorCap Heart Failure Device June 22
This article was originally published in The Gray Sheet
Executive Summary
Acorn Cardiovascular will present data from 300 patients when it appears before FDA's Circulatory System Devices Panel for review of the CorCap ventricular support device June 22